Prognostic Impact of the Systemic Immune-Inflammation Index in Unresectable Hepatocellular Carcinoma Undergoing Second-Line Combination Therapy: A Multicenter Study
{{output}}
Introduction: Patients with advanced hepatocellular carcinoma (HCC) who progress after first-line systemic therapy face a poor prognosis. This study evaluated the prognostic value of the baseline systemic immune-inflammation inde... ...
